Journal
MOLECULAR PSYCHIATRY
Volume 26, Issue 8, Pages 4265-4276Publisher
SPRINGERNATURE
DOI: 10.1038/s41380-020-0645-4
Keywords
-
Funding
- National Key Research and Development Program of China [2017YFA0505700]
- Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences [2019PT320002300]
- Natural Science Foundation Project of China [81820108015]
Ask authors/readers for more resources
Our study identified 23 differentially expressed metabolites in peripheral blood between MDD patients and controls. MDD patients showed higher levels of certain substances such as asymmetric dimethylarginine, tyramine, and 2-hydroxybutyric acid, and lower levels of others such as l-acetylcarnitine and l-methionine. l-tryptophan and kynurenic acid were consistently downregulated in MDD patients. The results suggest that metabolic changes in peripheral blood, particularly decreased levels of l-tryptophan and kynurenic acid, are associated with MDD.
Major depressive disorder (MDD) is a serious mental illness, characterized by high morbidity, which has increased in recent decades. However, the molecular mechanisms underlying MDD remain unclear. Previous studies have identified altered metabolic profiles in peripheral tissues associated with MDD. Using curated metabolic characterization data from a large sample of MDD patients, we meta-analyzed the results of metabolites in peripheral blood. Pathway and network analyses were then performed to elucidate the biological themes within these altered metabolites. We identified 23 differentially expressed metabolites between MDD patients and controls from 46 studies. MDD patients were characterized by higher levels of asymmetric dimethylarginine, tyramine, 2-hydroxybutyric acid, phosphatidylcholine (32:1), and taurochenodesoxycholic acid and lower levels of l-acetylcarnitine, creatinine, l-asparagine, l-glutamine, linoleic acid, pyruvic acid, palmitoleic acid, l-serine, oleic acid, myo-inositol, dodecanoic acid, l-methionine, hypoxanthine, palmitic acid, l-tryptophan, kynurenic acid, taurine, and 25-hydroxyvitamin D compared with controls. l-tryptophan and kynurenic acid were consistently downregulated in MDD patients, regardless of antidepressant exposure. Depression rating scores were negatively associated with decreased levels of l-tryptophan. Pathway and network analyses revealed altered amino acid metabolism and lipid metabolism, especially for the tryptophan-kynurenine pathway and fatty acid metabolism, in the peripheral system of MDD patients. Taken together, our integrated results revealed that metabolic changes in the peripheral blood were associated with MDD, particularly decreased l-tryptophan and kynurenic acid levels, and alterations in the tryptophan-kynurenine and fatty acid metabolism pathways. Our findings may facilitate biomarker development and the elucidation of the molecular mechanisms that underly MDD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available